Although we have only compared tumor development between Il22ra2–/– and Il22ra2+/+ mice on the Clec7a–/– background, these results suggest that enhanced expression of Il22ra2 in Clec7a–/– mice protects these mice from intestinal tumor development. The gene discussed is CLEC7A; the disease is intestinal neoplasm.